Page 2 of 5 · 112 questions tagged lipids.
I am reading the trial table rather than the press release, which is why the numbers differ. I can parse the result. I am less sure what it licenses me to conclude. I…
Conditions: magnesium · twelve weeks · orforglipron. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
Concretely: GGT · four weeks · dulaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether…
Setup, so nobody has to ask: lipase · two weeks · survodutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I…
I have three data points across nine months, which I hope is enough to see a trend. I want to understand what this actually establishes, as opposed to what it is…
The case in front of me: GGT · albumin-to-creatinine ratio · dulaglutide. I would like the axes of comparison first and the recommendation second. I have tried the…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
Twelve weeks in, losing roughly 1.1 kg a week, and my fasting LDL-C has gone from 2.7 to 3.3 mmol/L. Total cholesterol up from 4.6 to 5.2. Triglycerides down from 1.9…
I am reading the trial table rather than the press release, which is why the numbers differ. This is presented as though it settles something, and I am not convinced…
For reference: cystatin C · three weeks · a GLP-1 receptor agonist. An unexpected observation, and I would like a differential rather than reassurance. The conditions…
Stated plainly: creatinine · cystatin C · ecnoglutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
The specifics, since they change the answer: cystatin C · creatinine · cagrilintide. I am trying to choose between two options that are usually discussed as though…
Setup, so nobody has to ask: ALT · AST · ecnoglutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The clinician who ordered the panel was not concerned; I would still like to understand it. The figures are clear enough; the question is what they mean and what they…
Details up front: ApoB · ferritin · oral semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
My report has two kinds of number on it and I have been treating them as the same kind of thing. Some analytes come with an interval — "3.5 to 5.3", with my value…
The specifics, since they change the answer: AST · ALT · cagrilintide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
The specifics, since they change the answer: potassium · three weeks · cagrilintide. An unexpected observation, and I would like a differential rather than…
I have three numbers on my report that all claim to measure roughly the same risk and they do not agree about how I am doing. LDL-C 2.6 mmol/L, which is described in…
The case in front of me: magnesium · twelve weeks · dulaglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked…
Details up front: albumin-to-creatinine ratio · GGT · oral semaglutide. I have used one of these for a while and I am considering switching, which requires a reason.…
Details up front: TSH · six weeks · liraglutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate…
Numbers first: TSH · magnesium · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…